Brands and Their Owners
Welcome to the Brand page for “FOSFONOL”, which is offered here for Full line of pharmaceutical preparations for protection against and treatment of mutagenesis, radiation injury, side-effects of radiation therapy and chemotherapy, and carcinogenesis;.
Its status is currently believed to be active. Its class is unavailable. “FOSFONOL” is believed to be currently owned by “Hollis-Eden Pharmaceuticals, Inc.”
Owner: |
HOLLIS-EDEN PHARMACEUTICALS, INC.
Owner Details |
---|---|
Description: |
Full line of pharmaceutical preparations for protection against and treatment of mutagenesis, radiation injury, side-effects of radiation therapy and chemotherapy, and carcinogenesis;
|
Categories: | FULL LINE PHARMACEUTICAL PREPARATIONS |